Potential Link Between Untreated Sleep Apnea and Vascular Dementia Risk

New UK research reveals untreated obstructive sleep apnea may increase the risk of vascular dementia, underscoring the importance of proper diagnosis and treatment.
Recent research utilizing UK electronic health records indicates that untreated obstructive sleep apnea (OSA) may significantly increase the risk of developing vascular dementia. The comprehensive study analyzed data from 2.3 million individuals over a 12-year period, focusing on 193,000 patients diagnosed with OSA. Results revealed that these patients faced a 12% higher chance of developing overall dementia, with a notable 29% increased risk specifically for vascular dementia. Interestingly, the risk for Alzheimer's disease remained unaffected by sleep apnea.
Crucially, patients undergoing treatment with Continuous Positive Airway Pressure (CPAP), which assists in maintaining steady breathing during sleep, did not exhibit an elevated dementia risk compared to the general population. Additionally, female patients with sleep apnea did not demonstrate a heightened risk, suggesting gender differences in disease development.
Dr. Jingwa Wang of the University of Birmingham emphasized that untreated sleep apnea could contribute to cognitive decline, particularly vascular dementia, likely due to episodes of hypoxia—periods when oxygen levels are low in the body. The study employed the DExTER tool to analyze health records and compare outcomes between patients with and without OSA, highlighting the importance of managing sleep disorders.
Senior author Dr. Shamil Haroon highlighted the clinical implications, noting that conditions like sleep apnea may escalate the risk of dementia through mechanisms like hypoxia. He underscores the need for clinicians to recognize these risks and consider early interventions.
This research underscores the importance of diagnosing and properly managing sleep apnea to potentially reduce the associated risk of vascular cognitive deterioration.
Source: https://medicalxpress.com/news/2025-05-untreated-apnea-factor-vascular-dementia.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Study Questions the Protective Role of Education Against Cognitive Decline in Aging
Research involving over 170,000 participants questions the protective effect of education on cognitive decline, emphasizing the need for a holistic approach to brain health across the lifespan.
Innovative Technology Identifies Breast Cancer Relapses up to Five Years Early
A novel blood test developed by Altum Sequencing can predict breast cancer relapse up to five years in advance, revolutionizing post-treatment monitoring and early intervention strategies.
New Biologic Treatment Significantly Improves Outcomes in Severe Pulmonary Hypertension
A groundbreaking clinical trial shows that early use of sotatercept, a biologic drug, significantly reduces symptoms and hospitalizations in patients with severe pulmonary arterial hypertension, promising improved outcomes and earlier intervention benefits.
Innovative Gene Therapy Reduces Cardiac Arrhythmias Post-Heart Attack
Gene therapy targeting scar tissue post-heart attack shows potential in reducing dangerous cardiac arrhythmias by improving electrical conduction with connexin 43 expression.



